Brexit: EMA Could Lose Up To Half Its Staff If It Has To Move
Executive Summary
The European Medicines Agency is working to ensure it can cope with the many challenges it will face as a result of the UK leaving the EU. Those challenges could include the agency losing 50% of its staff, according to the EMA’s deputy head Noel Wathion.
You may also be interested in...
Rasi On Brexit: ‘EMA Is Well-Oiled Machine That We Cannot Afford To Start Stuttering’
European Medicines Agency head Guido Rasi tackles issue of Brexit in agency’s 2016 annual report, saying EMA is “core building block of the common market for medicines in the EU” that operates like “well-oiled machinery.”
Spain Woos EMA Staff With Offer of Free Spanish Lessons
Spanish bid for the European Medicines Agency post Brexit gets serious as delegation visits agency HQ in London to promote the “strong credentials” of Barcelona. Free Spanish lessons for staff will be on offer if the Catalan city is declared winner later this year.
Portugal Becomes EMA’s Latest Suitor As Agency Cost Pressures Grow
Portuguese officials are visiting the European Medicines Agency to tout the merits of Lisbon as its future home, but the financial pressures of Brexit are becoming clearer after the EMA management board said it could no longer set aside a special provision to cover the relocation costs.